0001104659-19-073113.txt : 20191216
0001104659-19-073113.hdr.sgml : 20191216
20191216172531
ACCESSION NUMBER: 0001104659-19-073113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191212
FILED AS OF DATE: 20191216
DATE AS OF CHANGE: 20191216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUYER DAVID R
CENTRAL INDEX KEY: 0001277476
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 191288128
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
a4.xml
4
X0306
4
2019-12-12
0
0001410939
IVERIC bio, Inc.
ISEE
0001277476
GUYER DAVID R
C/O IVERIC BIO, INC.
ONE PENN PLAZA, 35TH FLOOR
NEW YORK
NY
10119
1
1
0
0
Executive Chairman
Common Stock
2019-12-12
4
M
0
17200
A
60364
D
Common Stock
2019-12-13
4
S
0
9275
6.60
D
51089
D
Restricted Stock Units
2019-12-12
4
M
0
17200
0
D
Common Stock
17200
51600
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
On December 12, 2018, the Reporting Person was granted 68,800 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan.
/s/ Todd Anderman, as Attorney-in-Fact for David R. Guyer
2019-12-16